Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioXell SPA

Division of Cosmo Pharmaceuticals NV

Latest From BioXell SPA

Inotrem raises Europe's biggest Series A this year

An early-stage French company focused on developing a new treatment for sepsis says it has raised the largest series A financing in Europe to date in 2014. Inotrem, which was set up in 2013 around research work done at the University of Lorraine Medical School in Nancy, has completed a €18m fundraising led by Edmond de Rothschild Investment Partners and Sofinnova Partners.

Cardiovascular Cancer

Glenmark builds antibody expertise with Lay Line deal

Glenmark Pharmaceuticals has in-licensed the private Italian firm Lay Line Genomics' (LLG) intellectual property portfolio in the tyrosine kinase A (TrkA) field. The agreement includes LLG's BXL1H5, a monoclonal antibody that binds specifically to TrkA receptors.

Gastrointestinal Cardiovascular

Euro devaluation colours Cosmo profits in first half

A foreign exchange loss on the put option issued as part of its recent acquisition of BioXell dragged Italian firm Cosmo Pharmaceuticals' net profit down by 75% to €500,000 in the first half of 2010.

Gastrointestinal Dermatology

BioXell fails to find buyers for remaining assets ahead of Cosmo acquisition

BioXell, which is in the process of being acquired by fellow Italian firm Cosmo Pharmaceuticals, has ended efforts to divest its remaining technology assets.

Neurology Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • Cosmo Pharmaceuticals NV
  • Senior Management
  • Niels Ackermann, CEO
  • Contact Info
  • BioXell SPA
    Phone: (39) 02 21049 51
    Via Fratelli Cervi, Centro Direzionale
    di Milano 2
    Segrate, 20090